Deflox Tablets Bioequivalence (BE) Trial
Clinical trial NCT04132583 · COMPLETED
Trial details
- NCT number
- NCT04132583
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-21
- Primary completion
- 2019-10-27
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.